VYNE Therapeutics Inc. (VYNE)

Last Closing Price: 1.37 (2025-06-25)

Income after Taxes (Annual)

Income after Taxes: Earnings or losses after income tax expense but before minority interest, extraordinary items, discontinued operations, preferred dividends and accounting changes have been accounted for.

VYNE Therapeutics Inc. (VYNE) had Income after Taxes of $-39.81M for the most recently reported fiscal year, ending 2024-12-31.

Figures for fiscal year ending 2024-12-31
Income Statement Financials
$0.50M
$-39.83M
--
$0.50M
$44.14M
$-43.64M
$3.83M
$-39.80M
$-39.80M
Income after Taxes
$-39.81M
$-39.81M
$-39.83M
$-39.81M
$-43.64M
$-46.08M
42.59M
42.59M
$-0.93
$-0.93
Balance Sheet Financials
$64.44M
$0.11M
$2.47M
$66.91M
$14.82M
--
--
$14.82M
$52.09M
$52.09M
$52.09M
14.83M
Cash Flow Statement Financials
$-33.97M
$23.36M
$-0.14M
$30.67M
$19.93M
$-10.75M
$3.30M
--
--
Fundamental Metrics & Ratios
4.35
--
--
--
--
100.00%
-8709.98%
-8709.98%
-9196.81%
-7944.71%
-7950.90%
$-34.09M
--
--
--
0.01
--
--
--
-76.43%
-76.43%
-59.50%
-76.43%
$3.51
$-0.80
$-0.80